ATE420655T1 - Alpha-defensine als anthrax-immuntherapeutika - Google Patents

Alpha-defensine als anthrax-immuntherapeutika

Info

Publication number
ATE420655T1
ATE420655T1 AT05768232T AT05768232T ATE420655T1 AT E420655 T1 ATE420655 T1 AT E420655T1 AT 05768232 T AT05768232 T AT 05768232T AT 05768232 T AT05768232 T AT 05768232T AT E420655 T1 ATE420655 T1 AT E420655T1
Authority
AT
Austria
Prior art keywords
alpha
immunotherapeutics
defensins
anthrax
anthracis
Prior art date
Application number
AT05768232T
Other languages
English (en)
Inventor
Chun Kim
Stefan Kaufmann
Nadesan Gajendran
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Application granted granted Critical
Publication of ATE420655T1 publication Critical patent/ATE420655T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT05768232T 2004-07-22 2005-07-21 Alpha-defensine als anthrax-immuntherapeutika ATE420655T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04017392 2004-07-22

Publications (1)

Publication Number Publication Date
ATE420655T1 true ATE420655T1 (de) 2009-01-15

Family

ID=35355113

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05768232T ATE420655T1 (de) 2004-07-22 2005-07-21 Alpha-defensine als anthrax-immuntherapeutika

Country Status (6)

Country Link
US (1) US8227418B2 (de)
EP (1) EP1786453B1 (de)
AT (1) ATE420655T1 (de)
CA (1) CA2574477C (de)
DE (1) DE602005012401D1 (de)
WO (1) WO2006008162A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009043507A2 (en) * 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
TW201028154A (en) * 2008-10-23 2010-08-01 Novozymes As Antibiotic synergism

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242902A (en) * 1989-09-06 1993-09-07 The Regents Of The University Of California Defensin peptide compositions and methods for their use
US20040018193A1 (en) 2002-03-29 2004-01-29 Ken Alibek Rapid-acting broad spectrum protection against biological threat agents

Also Published As

Publication number Publication date
CA2574477A1 (en) 2006-01-26
US8227418B2 (en) 2012-07-24
DE602005012401D1 (en) 2009-03-05
EP1786453A1 (de) 2007-05-23
CA2574477C (en) 2014-08-19
EP1786453B1 (de) 2009-01-14
US20100143416A1 (en) 2010-06-10
WO2006008162A1 (en) 2006-01-26

Similar Documents

Publication Publication Date Title
NO20081844L (no) Terapeutiske forbindelser
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
EA200801275A1 (ru) Стабилизированные составы карбоната лантана
MX363189B (es) Productos químicos, composiciones y métodos para tratamiento y prevención de infecciones de virus orthopox y enfermedades asociadas.
TW200716646A (en) (S)-N-methylnaltrexone
EA201690265A3 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
MX2009009463A (es) Preparacion de una pelicula de rapida disolucion/desintegracion que tiene una alta proporcion de ingrediente activo.
IN2012DN01233A (de)
MX2011002966A (es) Formas de dosificacion farmaceutica que comprenden poli (e-caprolactona).
WO2008127364A3 (en) Antiviral compounds and use thereof
GEP20094784B (en) Sustained release pharmaceutical formulations
UA110199C2 (en) Solid rifaximin dispersion
TW200611695A (en) Pyrrolopyridine derivatives
PH12015501637A1 (en) Inactivated dengue virus vaccine with aluminium-free adjuvant
MX2010005012A (es) Composiciones para el tratamieno y prevencion de inflamacion de los parpados que comprenden un ingrediente osmoticamente activo y un vasocosntrictor.
WO2010111640A3 (en) Anti-influenza formulations and methods
EP2078083A4 (de) Neues hundeinfluenza-virus und imfpstoff hierfür
NO20091955L (no) Antivirale sammensetninger, og fremgangsmater for anvendelse
MA32841B1 (fr) Composés de cycloundeca depsipeptides et leur utilisation comme médicament
CY1115961T1 (el) Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate)
NO20076405L (no) Anvendelse av 24-nor-UDCA
WO2007044607A3 (en) Methods and compositions relating to anthrax spore glycoproteins as vaccines
ATE420655T1 (de) Alpha-defensine als anthrax-immuntherapeutika
MX2010000120A (es) Estereoisomeros de triciclodecan-9-il-xantogenato.
WO2007076091A3 (en) Treatment of viral infections using a tissue factor inhibitor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties